GSK

GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Their products are used by millions of people around the world, helping them to do more, feel better and live longer. They have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Their commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. By achieving th... is, they will be able to grow their business and provide benefits to patients, consumers, society, their employees and shareholders. With their headquarters in the UK, they have a wide geographical reach. They have offices in more than 115 countries, major research centres in the UK, USA, Spain, Belgium and China and an extensive manufacturing network with 87 sites globally. Research is vitally important to the success of their business, and they spent just under ยฃ4 billion in 2012 in their search to develop new medicines, vaccines and innovating consumer products.
GSK
Industry:
Consumer Health Care Pharmaceutical Venture Capital
Founded:
2000-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network COVID-19 QUIC New Relic Thing Schema SEO_H2 SEO_H1
Similar Organizations
Aperture Venture Partners
Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Brook Venture Partners
Brook Venture Partners is a Massachusetts-based company that provides capital to expansion-stage healthcare IT and tech-enabled services.
Duo Xi Yue Mu Ying Yue Zi Hui Suo
Duo Xi Yue Mu Ying Yue Zi Hui Suo provides scientific, healthy and cost-effective one-stop confinement services for confinement moms.
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Home Delivery Incontinent Supplies
Home Delivery Incontinent Supplies is specialized in providing quality care to those who experience loss of bladder control.
Lerer Hippeau
Lerer Hippeau is an early-stage venture capital fund founded and operated in New York City.
Maveron
Maveron is a consumer-only venture capital firm that empower consumers to live on their terms.
Mommi
Mommi is a consumer products company focused on enhancing womenโs lives, with an emphasis on the years surrounding pregnancy.
Therma Bright
THERMA BRIGHT is a progressive business in medical device development, focused on delivering affordable medical devices to customers.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Advisors List
Board_member
2021-04-01
Current Employees Featured
Jerome Andries SVP finance R&D @ GSK
SVP finance R&D
2017-08-01
Satish Maram Global Director ECommerce @ GSK
Global Director ECommerce
2020-07-01
Mehdi El Gueddari Principal Software Engineer @ GSK
Principal Software Engineer
Steven Harrison Senior Planning Engineer @ GSK
Senior Planning Engineer
Emma Walmsley CEO @ GSK
CEO
2017-01-01
Amy Labroo Director, Digital Marketing & OmniChannel @ GSK
Director, Digital Marketing & OmniChannel
2017-10-01
Jim Kennedy Product Manager / Tribe Leader NGS Vaccines @ GSK
Product Manager / Tribe Leader NGS Vaccines
2021-05-01
Patrick Vallance President, Pharmaceuticals R&D @ GSK
President, Pharmaceuticals R&D
Radu Rapiteanu Scientific Leader, Functional Genomics @ GSK
Scientific Leader, Functional Genomics
2020-11-01
Philip Thomson Senior Vice President, Global Communications @ GSK
Senior Vice President, Global Communications
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2018-10-08 | Sitryx Therapeutics | GSK investment in Series A - Sitryx Therapeutics | 30 M USD |
2015-06-15 | Calporta Therapeutics | GSK investment in Series A - Calporta Therapeutics | 10 M USD |
2015-06-01 | Cadherx Therapeutics | GSK investment in Series A - Cadherx Therapeutics | 10 M USD |
2012-10-25 | Thrasos | GSK investment in Series C - Thrasos | 35 M USD |
2011-07-08 | Springleaf Therapeutics | GSK investment in Series B - Springleaf Therapeutics | 19.05 M USD |
2010-07-30 | Anacor Pharmaceutical | GSK investment in Venture Round - Anacor Pharmaceutical | 15 M USD |
2009-02-06 | diaDexus | GSK investment in Post-IPO Equity - diaDexus | 9.2 M USD |
2009-01-06 | Anacor Pharmaceutical | GSK investment in Series E - Anacor Pharmaceutical | 50 M USD |
2008-04-30 | Concert Pharmaceuticals | GSK investment in Series C - Concert Pharmaceuticals | 37 M USD |
2008-02-13 | CalciMedica | GSK investment in Series B - CalciMedica | 5.5 M USD |
Newest Events participated
